Physician profile
Anmar Dalati
NPI 1316567555
$22,865.74
in general payments reported to CMS, 2019-2025
9 companies · $1,444 in 2025
The $1,444 reported for 2025 was more than what 75% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $21K · 2025: $1,444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $20K · Food and Beverage: $1,899 · Travel and Lodging: $967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $20,000.00 |
| Food and Beverage | $1,899.08 |
| Travel and Lodging | $966.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $20,332.33 | 2024-2025 | Proclaim |
| Boston Scientific Corporation | $847.06 | 2024-2025 | Accolade Sr |
| Globus Medical, INC. | $515.30 | 2025 | Senza, Mars |
| Nevro Corp. | $369.90 | 2024 | Senza |
| Medtronic, INC. | $310.30 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Stryker Corporation | $174.15 | 2025 | Mild Device Kit |
| Avanos Medical | $125.55 | 2024 | Generator |
| Vertex Pharmaceuticals Incorporated | $124.98 | 2025 | |
| Nalu Medical, INC. | $66.17 | 2024 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anmar Dalati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.